Literature DB >> 8383233

Role of maturation cleavage in infectivity of picornaviruses: activation of an infectosome.

W M Lee1, S S Monroe, R R Rueckert.   

Abstract

Maturation of picornaviruses involves assembly of a "provirion," which undergoes an autocatalytic cleavage of VP0 to VP2 plus VP4. RNA transcripts from a cDNA clone of human rhinovirus 14 mutated at asparagine 68, one of the residues in the maturation cleavage site, generated normal yields of 150S particles which were noninfectious in the plaque assay because they were unable to initiate a second cycle of infection. These cleavage-defective provirions were otherwise indistinguishable from mature virions in sedimentation coefficient, binding affinity to monoclonal antibodies against neutralization sites IA, II, and III, attachment to HeLa cell receptors, and rate of cell-mediated conformational changes to form 125S A-particles and 80S empty capsids. These results suggest that maturation cleavage is required for the function of a previously undescribed intermediate which transfers packaged RNA across the membrane and into the cytosol. For this hypothetical intermediate, we propose the name infectosome. Since the native virus has a particle/PFU ratio of about 800, such an intermediate will be difficult to find. Mutations at serine 10 in VP2 reduced maturation cleavage to a rate sufficiently slow to show that the infectivity of virus particles increased with the degree of cleavage of VP0 to VP4 and VP2. This article describes the first characterization of a pure form of a picornaviral provirion, and hence the first direct evidence that provirions of picornaviruses lack infectivity.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8383233      PMCID: PMC240305     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  46 in total

1.  A possible precursor containing RNA of a bovine enterovirus: the provirion 11.

Authors:  E M Hoey; S J Martin
Journal:  J Gen Virol       Date:  1974-09       Impact factor: 3.891

2.  On the structure of rhinovirus 1A.

Authors:  K C Medappa; C McLean; R R Rueckert
Journal:  Virology       Date:  1971-05       Impact factor: 3.616

3.  The complete nucleotide sequence of a common cold virus: human rhinovirus 14.

Authors:  G Stanway; P J Hughes; R C Mountford; P D Minor; J W Almond
Journal:  Nucleic Acids Res       Date:  1984-10-25       Impact factor: 16.971

4.  A simple and very efficient method for generating cDNA libraries.

Authors:  U Gubler; B J Hoffman
Journal:  Gene       Date:  1983-11       Impact factor: 3.688

5.  Unidirectional digestion with exonuclease III creates targeted breakpoints for DNA sequencing.

Authors:  S Henikoff
Journal:  Gene       Date:  1984-06       Impact factor: 3.688

6.  In situ detection of mycoplasma contamination in cell cultures by fluorescent Hoechst 33258 stain.

Authors:  T R Chen
Journal:  Exp Cell Res       Date:  1977-02       Impact factor: 3.905

7.  A comprehensive set of sequence analysis programs for the VAX.

Authors:  J Devereux; P Haeberli; O Smithies
Journal:  Nucleic Acids Res       Date:  1984-01-11       Impact factor: 16.971

8.  Adenosine phosphorylase-mediated nucleoside toxicity. Application towards the detection of mycoplasmal infection in mammalian cell cultures.

Authors:  G J McGarrity; D A Carson
Journal:  Exp Cell Res       Date:  1982-05       Impact factor: 3.905

9.  Elimination of mycoplasmas from cell cultures and establishment of mycoplasma-free cell lines.

Authors:  J Schmidt; V Erfle
Journal:  Exp Cell Res       Date:  1984-06       Impact factor: 3.905

10.  Morphogenesis of poliovirus. II. Demonstration of a new intermediate, the proviron.

Authors:  C B Fernandez-Tomas; D Baltimore
Journal:  J Virol       Date:  1973-11       Impact factor: 5.103

View more
  75 in total

1.  Uncoating kinetics of hepatitis A virus virions and provirions.

Authors:  N E Bishop; D A Anderson
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

2.  Sites and determinants of early cleavages in the proteolytic processing pathway of reovirus surface protein sigma3.

Authors:  Judit Jané-Valbuena; Laura A Breun; Leslie A Schiff; Max L Nibert
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

3.  Sequence requirements for viral RNA replication and VPg uridylylation directed by the internal cis-acting replication element (cre) of human rhinovirus type 14.

Authors:  Yan Yang; Rene Rijnbrand; Kevin L McKnight; Eckard Wimmer; Aniko Paul; Annette Martin; Stanley M Lemon
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

4.  Putative autocleavage of outer capsid protein micro1, allowing release of myristoylated peptide micro1N during particle uncoating, is critical for cell entry by reovirus.

Authors:  Amy L Odegard; Kartik Chandran; Xing Zhang; John S L Parker; Timothy S Baker; Max L Nibert
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

Review 5.  Foot-and-mouth disease.

Authors:  Marvin J Grubman; Barry Baxt
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

6.  Picornaviruses.

Authors:  Tobias J Tuthill; Elisabetta Groppelli; James M Hogle; David J Rowlands
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

7.  Determinants of strain-specific differences in efficiency of reovirus entry.

Authors:  Payel Sarkar; Pranav Danthi
Journal:  J Virol       Date:  2010-10-13       Impact factor: 5.103

8.  Production, purification, and capsid stability of rhinovirus C types.

Authors:  Theodor F Griggs; Yury A Bochkov; Kazuyuki Nakagome; Ann C Palmenberg; James E Gern
Journal:  J Virol Methods       Date:  2015-02-24       Impact factor: 2.014

9.  Infection and propagation of human rhinovirus C in human airway epithelial cells.

Authors:  Weidong Hao; Katie Bernard; Nita Patel; Nancy Ulbrandt; Hui Feng; Catherine Svabek; Susan Wilson; Christina Stracener; Kathy Wang; Joann Suzich; Wade Blair; Qing Zhu
Journal:  J Virol       Date:  2012-10-03       Impact factor: 5.103

10.  Allergen challenge in vivo alters rhinovirus-induced chemokine secretion from human airway macrophages.

Authors:  Maya R Karta; Lisa E Wickert; Colleen S Curran; Monica L Gavala; Loren C Denlinger; James E Gern; Paul J Bertics
Journal:  J Allergy Clin Immunol       Date:  2014-02-14       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.